Although the roles of eotaxin in ovarian cancer have not been extensively studied, it is known that eotaxin induction increases CD8-positive T cell recruitment to the TME in non-small lung cancer (Gao et al., 2019), promotes antitumor immunity and is associated with increased survival in colorectal cancer (Cao et al., 2021). This evidence concerns the gene CD8A and ovarian carcinoma.